McIntyre; Charles J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for McIntyre; Charles J..The latest application filed is for "hcv ns3 protease inhibitors".
- McIntyre; Charles J. - Cambridge MA
- McIntyre; Charles J. - Landsdale PA
- McIntyre; Charles J. - Lansdale PA US
- McIntyre, Charles J - Lansdale PA
| Patent | Date |
|---|---|
| HCV NS3 Protease Inhibitors App 20150266897 - Liverton; Nigel J. ; et al. | 2015-09-24 |
| Therapeutic compounds Grant 8,591,878 - McCauley , et al. November 26, 2 | 2013-11-26 |
| HCV NS3 protease inhibitors Grant 8,461,107 - Liverton , et al. June 11, 2 | 2013-06-11 |
| Isoquinolinone potassium channel inhibitors Grant 8,338,449 - Trotter , et al. December 25, 2 | 2012-12-25 |
| HCV NS3 protease inhibitors Grant 8,216,999 - Holloway , et al. July 10, 2 | 2012-07-10 |
| Hcv Ns3 Protease Inhibitors App 20110046161 - Liverton; Nigel J. ; et al. | 2011-02-24 |
| Therapeutic Compounds App 20110002884 - McCauley; John A. ; et al. | 2011-01-06 |
| Isoquinolinone Potassium Channel Inhibitors App 20100256698 - Trotter; B. Wesley ; et al. | 2010-10-07 |
| Isoquinolinone potassium channel inhibitors Grant 7,781,457 - Isaacs , et al. August 24, 2 | 2010-08-24 |
| Isoquinoline potassium channel inhibitors Grant 7,763,614 - Isaacs , et al. July 27, 2 | 2010-07-27 |
| Isoquinolinone potassium channel inhibitors Grant 7,741,322 - Dinsmore , et al. June 22, 2 | 2010-06-22 |
| Isoquinolinone potassium channel inhibitors Grant 7,723,352 - Trotter , et al. May 25, 2 | 2010-05-25 |
| Isoquinolinone potassium channel inhibitors Grant 7,709,476 - Dinsmore , et al. May 4, 2 | 2010-05-04 |
| Hcv Ns3 Protease Inhibitors App 20090124661 - HOLLOWAY; M. Katharine ; et al. | 2009-05-14 |
| HCV NS3 protease inhibitors Grant 7,470,664 - Holloway , et al. December 30, 2 | 2008-12-30 |
| 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists Grant 7,452,893 - Thompson , et al. November 18, 2 | 2008-11-18 |
| Isoquinolinone Potassium Channel Inhibitors App 20080227778 - Dinsmore; Christopher J. ; et al. | 2008-09-18 |
| (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds Grant 7,196,095 - Biftu , et al. March 27, 2 | 2007-03-27 |
| Isoquinoline potassium channel inhibitors App 20070054892 - Isaacs; Richard ; et al. | 2007-03-08 |
| 4-Cycloakylaminopyrazolo pyrimidine nmda/nr2b antagonists App 20070037829 - Thompson; Wayne ; et al. | 2007-02-15 |
| Isoquinolinone potassium channel inhibitors App 20070027177 - Trotter; B. Wesley ; et al. | 2007-02-01 |
| HCV NS3 protease inhibitors App 20070027071 - Holloway; M. Katharine ; et al. | 2007-02-01 |
| Isoquinolinone potassium channel inhibitors App 20060270704 - Isaacs; Richard ; et al. | 2006-11-30 |
| Isoquinolinone potassium channels inhibitors Grant 6,870,055 - Claremon , et al. March 22, 2 | 2005-03-22 |
| 4-Cycloalkylaminopyrazolo pyrimidine NMDA/NR2B antagonists App 20050054658 - Thompson, Wayne ; et al. | 2005-03-10 |
| (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds App 20040176396 - Biftu, Tesfaye ; et al. | 2004-09-09 |
| Isoquinolinone potassium channels inhibitors App 20040044030 - Claremon, David A ; et al. | 2004-03-04 |
| Substituted pyridazines having cytokine inhibitory activity Grant 6,602,872 - McIntyre , et al. August 5, 2 | 2003-08-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 